A detailed history of Flagship Harbor Advisors, LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Flagship Harbor Advisors, LLC holds 13,145 shares of EW stock, worth $869,673. This represents 0.05% of its overall portfolio holdings.

Number of Shares
13,145
Previous 11,477 14.53%
Holding current value
$869,673
Previous $1.1 Million 20.89%
% of portfolio
0.05%
Previous 0.07%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

BUY
$59.7 - $93.78 $99,579 - $156,425
1,668 Added 14.53%
13,145 $867,000
Q1 2024

Apr 16, 2024

BUY
$72.54 - $95.56 $870 - $1,146
12 Added 0.1%
11,477 $1.1 Million
Q4 2023

Jan 10, 2024

BUY
$61.71 - $77.76 $73,990 - $93,234
1,199 Added 11.68%
11,465 $874,000
Q3 2023

Oct 17, 2023

BUY
$69.28 - $93.38 $62,836 - $84,695
907 Added 9.69%
10,266 $711,000
Q2 2023

Jul 11, 2023

SELL
$81.41 - $94.33 $12,944 - $14,998
-159 Reduced 1.67%
9,359 $882,000
Q1 2023

Apr 12, 2023

BUY
$74.26 - $84.51 $24,580 - $27,972
331 Added 3.6%
9,518 $787,000
Q4 2022

Jan 13, 2023

BUY
$68.3 - $87.44 $92,546 - $118,481
1,355 Added 17.3%
9,187 $0
Q3 2022

Oct 13, 2022

BUY
$82.37 - $107.29 $27,593 - $35,942
335 Added 4.47%
7,832 $647,000
Q2 2022

Jul 13, 2022

SELL
$86.5 - $128.27 $12,715 - $18,855
-147 Reduced 1.92%
7,497 $713,000
Q1 2022

Apr 13, 2022

SELL
$101.96 - $128.34 $9,176 - $11,550
-90 Reduced 1.16%
7,644 $900,000
Q4 2021

Feb 10, 2022

SELL
$106.37 - $130.68 $23,188 - $28,488
-218 Reduced 2.74%
7,734 $1 Million
Q2 2021

Jul 26, 2021

SELL
$83.84 - $104.76 $59,023 - $73,751
-704 Reduced 8.13%
7,952 $824,000
Q1 2021

May 03, 2021

BUY
$78.68 - $90.67 $37,058 - $42,705
471 Added 5.75%
8,656 $724,000
Q4 2020

Feb 08, 2021

SELL
$71.69 - $91.23 $5,089 - $6,477
-71 Reduced 0.86%
8,185 $747,000
Q3 2020

Oct 13, 2020

BUY
$67.19 - $87.44 $61,881 - $80,532
921 Added 12.56%
8,256 $658,000
Q2 2020

Jul 31, 2020

BUY
$57.54 - $76.95 $295,122 - $394,676
5,129 Added 232.5%
7,335 $506,000
Q1 2020

May 12, 2020

BUY
$52.41 - $81.0 $30,712 - $47,466
586 Added 36.17%
2,206 $416,000
Q4 2019

Feb 14, 2020

SELL
$71.7 - $82.09 $4,660 - $5,335
-65 Reduced 3.86%
1,620 $378,000
Q3 2019

Oct 22, 2019

SELL
$61.55 - $75.43 $11,325 - $13,879
-184 Reduced 9.84%
1,685 $370,000
Q2 2019

Jul 22, 2019

BUY
$55.74 - $64.41 $8,249 - $9,532
148 Added 8.6%
1,869 $345,000
Q1 2019

Apr 15, 2019

BUY
$47.89 - $64.05 $766 - $1,024
16 Added 0.94%
1,721 $329,000
Q4 2018

Jan 28, 2019

SELL
$46.41 - $56.94 $835 - $1,024
-18 Reduced 1.04%
1,705 $261,000
Q3 2018

Nov 05, 2018

BUY
$45.7 - $58.03 $228 - $290
5 Added 0.29%
1,723 $294,000
Q2 2018

Aug 14, 2018

SELL
$42.45 - $51.3 $636 - $769
-15 Reduced 0.87%
1,718 $250,000
Q1 2018

Apr 24, 2018

SELL
$37.19 - $47.45 $13,946 - $17,793
-375 Reduced 17.79%
1,733 $234,000
Q4 2017

Jan 24, 2018

BUY
$33.79 - $39.39 $71,229 - $83,034
2,108
2,108 $252,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $40.9B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Flagship Harbor Advisors, LLC Portfolio

Follow Flagship Harbor Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Flagship Harbor Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Flagship Harbor Advisors, LLC with notifications on news.